SEC 13F Intelligence

Saturna Capital Corp / ABBV

Saturna Capital Corp’s Abbvie Inc Position

Does Saturna Capital Corp own Abbvie Inc (ABBV)? Yes781.7K shares worth $170M (+2.39% of its 13F portfolio) as of Q1 2026, up from 780.3K shares the prior filed quarter.

Position Value
$170M
Q1 2026
Shares
781.7K
% of Portfolio
+2.39%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $37MQ4 ’18Q1 ’19: $33MQ2 ’19: $29MQ3 ’19: $28MQ4 ’19: $32MQ4 ’19Q1 ’20: $28MQ2 ’20: $36MQ3 ’20: $32MQ4 ’20: $32MQ4 ’20Q1 ’21: $40MQ2 ’21: $41MQ3 ’21: $39MQ4 ’21: $50MQ4 ’21Q1 ’22: $59MQ2 ’22: $30MQ3 ’22: $21MQ4 ’22: $25MQ4 ’22Q1 ’23: $18MQ2 ’23: $15MQ3 ’23: $17MQ4 ’23: $18MQ4 ’23Q1 ’24: $21MQ2 ’24: $20MQ3 ’24: $134MQ4 ’24: $120MQ4 ’24Q1 ’25: $150MQ2 ’25: $133MQ3 ’25: $173MQ4 ’25: $178MQ4 ’25Q1 ’26: $170Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026781.7K$170M+2.39%
Q4 2025780.3K$178M+2.36%
Q3 2025749.1K$173M+2.24%
Q2 2025719.0K$133M+1.80%
Q1 2025717.2K$150M+2.25%
Q4 2024676.7K$120M+1.63%
Q3 2024676.2K$134M+1.75%
Q2 2024115.4K$20M+0.26%
Q1 2024115.4K$21M+0.29%
Q4 2023114.8K$18M+0.28%
Q3 2023113.5K$17M+0.30%
Q2 2023113.4K$15M+0.26%
Q1 2023111.6K$18M+0.34%
Q4 2022156.1K$25M+0.54%
Q3 2022156.3K$21M+0.51%
Q2 2022196.0K$30M+0.71%
Q1 2022365.9K$59M+1.20%
Q4 2021365.5K$50M+0.89%
Q3 2021365.7K$39M+0.79%
Q2 2021365.7K$41M+0.84%
Q1 2021365.9K$40M+0.88%
Q4 2020365.9K$32M+0.82%
Q3 2020365.9K$32M+0.85%
Q2 2020365.9K$36M+1.01%
Q1 2020365.8K$28M+0.90%
Q4 2019366.5K$32M+0.88%
Q3 2019370.5K$28M+0.81%
Q2 2019401.5K$29M+0.86%
Q1 2019406.6K$33M+0.96%
Q4 2018406.6K$37M+1.26%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Saturna Capital Corp’s full portfolio or all institutional holders of ABBV.